Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 3:31 pm Purchase | 13G | INHIBIKASE THERAPEUTICS INC CO IKT | ARMISTICE CAPITAL LLC | 758,885 9.990% | 758,885 (New Position) | View |
| 2024-10-28 5:26 pm Purchase | 13G | INHIBIKASE THERAPEUTICS INC CO IKT | SP IKT Holdings LLC | 5,840,000 8.690% | 5,840,000 (New Position) | View |
| 2024-10-28 4:00 pm Purchase | 13G | INHIBIKASE THERAPEUTICS INC CO IKT | Soleus Private Equity Fund III L.P. | 7,228,908 9.990% | 7,228,908 (New Position) | View |
| 2024-10-25 5:50 pm Purchase | 13G | INHIBIKASE THERAPEUTICS INC CO IKT | Sands Capital Life Sciences Pulse Fund II L.P. | 10,950,000 16.300% | 10,950,000 (New Position) | View |
| 2024-10-22 4:15 pm Purchase | 13G | INHIBIKASE THERAPEUTICS INC CO IKT | PERCEPTIVE ADVISORS LLC | 6,799,944 9.990% | 6,799,944 (New Position) | View |
| 2024-10-17 7:00 pm Purchase | 13G | INHIBIKASE THERAPEUTICS INC CO IKT | Fairmount Funds Management LLC | 6,620,311 9.900% | 6,620,311 (New Position) | View |
| 2024-10-17 4:05 pm Purchase | 13G | INHIBIKASE THERAPEUTICS INC CO IKT | COMMODORE CAPITAL LP | 6,807,507 9.990% | 6,807,507 (New Position) | View |
| 2024-10-10 4:10 pm Purchase | 13G | INHIBIKASE THERAPEUTICS INC CO IKT | Point72 Asset Management L.P. | 625,000 8.400% | 625,000 (New Position) | View |
| 2023-02-24 12:27 pm Sale | 13D | INHIBIKASE THERAPEUTICS INC CO IKT | FiveT Investment Management Ltd | 1,341,000 4.780% | -176,000 (-11.60%) | View |
| 2023-02-15 7:45 pm Purchase | 13G | INHIBIKASE THERAPEUTICS INC CO IKT | Werner Milton H. | 5,558,912 19.680% | 100,874 (+1.85%) | View |
| 2023-01-31 11:59 am Unchanged | 13D | INHIBIKASE THERAPEUTICS INC CO IKT | FiveT Investment Management Ltd | 1,517,000 4.120% | 0 (Unchanged) | View |
| 2022-02-11 5:15 pm Purchase | 13G | INHIBIKASE THERAPEUTICS INC CO IKT | Werner Milton H. | 5,458,038 21.700% | 16,415 (+0.30%) | View |
| 2022-01-11 12:04 pm Purchase | 13D | INHIBIKASE THERAPEUTICS INC CO IKT | FiveT Investment Management Ltd | 1,517,000 6.030% | 267,000 (+21.36%) | View |
| 2021-12-15 12:52 pm Sale | 13D | INHIBIKASE THERAPEUTICS INC CO IKT | FiveT Investment Management Ltd | 1,250,000 4.970% | -214,715 (-14.66%) | View |
| 2021-06-21 12:01 pm Purchase | 13D | INHIBIKASE THERAPEUTICS INC CO IKT | FiveT Investment Management Ltd | 1,464,715 5.830% | 1,464,715 (New Position) | View |
| 2021-03-23 1:32 pm Purchase | 13G | INHIBIKASE THERAPEUTICS INC CO IKT | Kalman Daniel | 1,748,312 14.800% | 1,748,312 (New Position) | View |
| 2021-02-11 4:06 pm Purchase | 13G | INHIBIKASE THERAPEUTICS INC CO IKT | Werner Milton H. | 5,441,623 53.100% | 5,441,623 (New Position) | View |